AI Article Synopsis
Article Abstract
Background: Pathological factors, based mainly on immunohistochemistry (IHC) and histological differentiation, are mostly used to differentiate breast cancer (BC) subtypes. Our present aim was to describe the characteristics and survival of a relapsing BC patient cohort based on clinico-pathologic subtypes determined for the primary tumors. Methods: We used a clinico- pathological definition of BC subtypes based on histological grade (HG), estrogen receptor (ER), progesterone receptor (PgR),and epidermal growth factor receptor type 2 (HER2) expression assessed by IHC. We determined variables associated with loco-regional recurrence (LRR), second primaries (SP), systemic recurrence (SR) and post-recurrence survival (PRS). Results: Out of 1,702 patients, 240 (14%) had an event defined as recurrence. Those with recurrent disease were significantly younger than those without,and were initially diagnosed at more advanced stages, with larger tumors, greater lymph nodal involvement and higher HG. With a median follow up of 61 months (1-250), 4.6% of patients without recurrence and 56.6% of patients with an event defined as recurrence had died. The median PRS for the LRR group was 77 months; 75 months for those who developed a SP and 22 months for patients with an SR (p <0.0001). In SR cases, the median PRS was shorter for ER- tumors than for ER+ tumors (15 vs. 26 months, respectively; p = 0.0019, HR 0.44; CI: 0.25-0.44). Conclusions: Subtype, defined through classic histopathologic parameters determined for primary tumors, was found to eb related to type of recurrence and also to prognosis after relapse.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5454640 | PMC |
| http://dx.doi.org/10.22034/APJCP.2016.17.12.5081 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Prevalence and Clinico-pathologic Profile of Biopsied Gingival Lesions from 2 Thai Dental Schools.
J Clin Exp Dent
September 2024
College of Dental Medicine, Rangsit University.
Article Synopsis
- The study examined the prevalence and characteristics of gingival lesions at Chulalongkorn and Rangsit Dental Schools in Thailand, reviewing biopsy records from 1995 to 2020.
- Out of 16,207 biopsies, 1,589 (10.2%) were gingival lesions, most commonly occurring in patients around 42 years old, predominantly affecting females and found mainly in the posterior mandible.
- Non-neoplastic lesions like pyogenic granuloma were the most common, and the study highlights the unique findings in the Thai population compared to other countries.
Development of predictive models for pathological response status in breast cancer after neoadjuvant therapy based on peripheral blood inflammatory indexes.
BMC Womens Health
October 2024
Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China.
Article Synopsis
- Achieving a pathological complete response (pCR) after neoadjuvant therapy (NAT) is crucial for better breast cancer prognosis, but discordant responses (DpCR) show mixed results needing further investigation of predictive factors.
- This study analyzed 789 breast cancer patients, using statistical methods to identify which factors can best predict responses to NAT, leading to the creation of models based on clinical traits and blood inflammatory markers.
- Key findings included the development of models that effectively distinguish between traditional non pCR (T-NpCR) and total pCR (TpCR) responses, highlighting HALP and FAR as significant blood markers for predicting NAT outcomes.
Elevated expression of Aurora-A/AURKA in breast cancer associates with younger age and aggressive features.
Breast Cancer Res
August 2024
Department of Clinical Medicine, Section for Pathology, Centre for Cancer Biomarkers CCBIO, University of Bergen, Bergen, Norway.
Background And Objective: Aurora kinase A (AURKA) is reported to be overexpressed in breast cancer. In addition to its role in regulating cell cycle and mitosis, studies have reported AURKA involvements in oncogenic signaling in suppressing BRCA1 and BRCA2. We aimed to characterize AURKA protein and mRNA expression in a breast cancer cohort of the young, investigating its relation to clinico-pathologic features and survival, and exploring age-related AURKA-associated biological processes.
View Article and Find Full Text PDFIncidence and Prognostic Significance of Androgen Receptors (AR) in Indian Triple-Negative Breast Cancer (TNBC).
Indian J Surg Oncol
June 2024
Department of Endocrine Surgery, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Raebareli Road, Lucknow, 226014 India.
Molecular sub-characterization of triple-negative breast cancer (TNBC) has great therapeutic and possibly prognostic implications. The primary aim of this study was to investigate the incidence of luminal androgen receptor (LAR) subtype of TNBC and secondary aims were sub-categorization and clinico-pathologic correlation of LAR breast cancers. Retrospective study () consisting of 157 TNBC patients.
View Article and Find Full Text PDFClinico-pathologic factors and survival of patients with breast cancer diagnosed with de novo brain metastasis: a national cancer database analysis.
Breast Cancer Res Treat
August 2024
Department of Hematology and Oncology, Cleveland Clinic Florida, 2950 Cleveland Clinic Blvd, Weston, FL, 33331, USA.
Purpose: Patients with Breast Cancer (BC) with Brain Metastasis (BCBM) have poor survival outcomes. We aimed to explore the clinico-pathologic and therapeutic factors predicting the survival in patients with de novo BCBM using the National Cancer Database (NCDB).
Patients And Methods: The NCDB was queried for patients with BC between 2010 and 2020.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!